← Back
$MBRX All transactions

Moleculin Biotech, Inc.

A

$ Value

Shares

830,000

Price

Filed

Nov 14

Insider

Name

KLEMP WALTER V

Title

CEO and President

CIK

0000938419

Roles

Director Officer

Transaction Details

Transaction Date

2025-11-12

Code

A

Table

Derivative

Ownership

Direct

Equity Swap

No

Shares After

3,210,731

Footnotes

The stock option set forth in this table vests in four equal annual installments beginning on the first anniversary of the Transaction Date, subject to the grantee's continued service to the Company on each vesting date. | Issued in connection with the reporting person's employment with the Company. | Each restricted stock unit represents a contingent right to receive one shares of Company common stock. | On November 12, 2025, the Board approved this performance based restricted stock unit. The performance based restricted stock units set forth in this table will vest in 20% installments upon the achievement of certain clinical milestones; provided that upon a change of control (as defined in the 2024 Stock Plan) 100% shall vest.

Filing Info

Accession No.

0001437749-25-035182

Form Type

4

Issuer CIK

0001659617

KLEMP WALTER V's History

Date Ticker Type Value
2025-11-12 MBRX A
2025-11-12 MBRX A
2025-11-04 MBRX M
2025-11-04 MBRX F $3K
2025-11-04 MBRX M $0
2025-08-11 AMIX D
2025-06-23 MBRX $250K
2025-06-23 MBRX
2025-06-22 MBRX M
2025-06-22 MBRX F $585

Other Insiders at MBRX (90d)

No other insider activity at this issuer in the last 90 days.